Data presented at ASCO shows Biscayne's anti-cancer target is expressed in all subtyp
Biscayne Pharmaceuticals, Inc., has announced that data supporting the anti-cancer potential of its growth hormone-releasing hormone (GHRH) technology was discussed in a poster presentation at the...